Back to DE D. E. Shaw & Co., Inc.

ALNYALNY
Showing 8 of 31 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in ALNYLAM PHARMACEUTICALS INC

D. E. Shaw & Co., Inc. holds 1.1M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $332.4M as of 2026-Q2. The position was increased (+4.3% shares). ALNY represents 0.2% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$332.4M

Current Shares

1.1M

Total Value Change

+$241M

Total Shares Change

+771,804

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+4.3%
$332.4M0.2%$301.03
39
2026-Q1
Increased
1.1M
+138.3%
$350.4M0.2%$330.87
60
2025-Q4
Increased
444,493
+122.9%
$176.8M0.1%$397.65
49
2025-Q3
Increased
199,417
+84.2%
$90.9M0.1%$456.00
46
2025-Q2
Decreased
108,276
-62.6%
$35.3M0.0%$326.09
0
2025-Q1
Decreased
289,862
-20.2%
$78.3M0.1%$270.02
0
2024-Q4
Increased
363,085
+9.3%
$85.4M0.1%$235.31
33
2024-Q3
Increased
332,305
+18.9%
$91.4M0.1%$275.03
35

Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used